drugset / Trial / NCT05864625

Comparison of Hemodynamic Stability During Anesthesia Using Remimazolam and Sevoflurane in Minimally Invasive AVR

NCT05864625

RandomizedParallel-groupSingle-blindOther

Summary

Anesthetic agents can cause hypotension, and be especially dangerous in patients with severe aortic stenosis, which can lead to even circulatory collapse. Remimazolam is known for its hemodynamic stability compared to propofol. This study is designed to compare effects of remimazolam vs. sevoflurane anesthesia on intraoperative hemodynamics in patients with severe aortic valve stenosis.

Timeline

Start
2023-06-29
Primary completion
2025-06-10
Completion
2025-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1 mg/kg
Comparator Propofol Small molecule 2 mg/kg
Subject Remimazolam Small molecule 1 mg/kg Intravenous
Subject Remimazolam Small molecule 2 mg/kg Intravenous
Comparator Sevoflurane Other / unclassified

Indications